{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:10:16Z","timestamp":1761844216493},"reference-count":8,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2012,9,17]]},"published-print":{"date-parts":[[2013,3]]},"abstract":"<jats:p>Methylnaltrexone, a peripheral opioid \u03bc-receptor antagonist is licensed for subcutaneous administration for the treatment of severe opioid-induced constipation in adults. We describe the use of intravenous methylnaltrexone in a 3-year-old boy receiving a subcutaneous diamorphine infusion for palliation from widely metastatic alveolar rhabdomyosarcoma. The patient, who had not opened his bowels for 3\u2005weeks despite use of regular conventional laxatives, was given a 150 mcg\/kg dose via indwelling central venous catheter. Constipation was relieved within minutes of the injection. There were no side effects noted during or following injection, and no clinically apparent reduction in analgesia. Intravenous methylnaltrexone may provide a valuable additional treatment option in paediatric palliative care, especially for those with an oncological diagnosis, the majority of whom will have indwelling central venous access devices.<\/jats:p>","DOI":"10.1136\/bmjspcare-2012-000291","type":"journal-article","created":{"date-parts":[[2012,11,3]],"date-time":"2012-11-03T01:27:27Z","timestamp":1351906047000},"page":"103-105","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Paediatric palliative care: intravenous methylnaltrexone relieves constipation"],"prefix":"10.1136","volume":"3","author":[{"given":"Daniel","family":"Yeomanson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Chohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2012,11,1]]},"reference":[{"key":"2024051610203542000_3.1.103.1","first-page":"247","article-title":"Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation","volume":"4","author":"Deibert","year":"2010","journal-title":"Core Evid"},{"key":"2024051610203542000_3.1.103.2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4137\/CMO.S4867","article-title":"Opioid-induced constipation in advanced illness: safety and efficacy of methylnaltrexone bromide","volume":"5","author":"Bader","year":"2011","journal-title":"Clin Med Insights Oncol"},{"key":"2024051610203542000_3.1.103.3","doi-asserted-by":"crossref","unstructured":"Candy B Jones L Goodman ML . Laxatives or methylnaltrexone for the management of constipation in palliative care patients. Cochrane Database Syst Rev 2011;(1):CD003448. doi: 10.1002\/14651858.CD003448.pub3","DOI":"10.1002\/14651858.CD003448.pub3"},{"key":"2024051610203542000_3.1.103.4","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004273491"},{"key":"2024051610203542000_3.1.103.5","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.1016\/j.jpedsurg.2010.10.015","article-title":"Resolution of opioid-induced postoperative ileus in a newborn infant after methylnaltrexone","volume":"46","author":"Garten","year":"2011","journal-title":"J Pediatr Surg"},{"key":"2024051610203542000_3.1.103.6","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2011-300213"},{"key":"2024051610203542000_3.1.103.7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/AJP.0b013e31822ad94c","article-title":"Methylnaltrexone in treatment of opioid-induced constipation in a pediatric patient","volume":"28","author":"Lee","year":"2012","journal-title":"Clin J Pain"},{"key":"2024051610203542000_3.1.103.8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jpainsymman.2012.04.001","article-title":"Methylnaltrexone for opioid-induced constipation in a pediatric oncology patient","volume":"44","author":"Kissling","year":"2012","journal-title":"J Pain Symptom Manage"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjspcare-2012-000291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T17:20:47Z","timestamp":1715880047000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/bmjspcare-2012-000291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,1]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,3,1]]},"published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1136\/bmjspcare-2012-000291"],"URL":"https:\/\/doi.org\/10.1136\/bmjspcare-2012-000291","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,1]]}}}